Search clinical trials for: Histamine H1 Antagonists

Total 33159 results

Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Sanofi

Completed

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis

United States
Organon and Co

Completed

Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

Allergic Airway Disease
GlaxoSmithKline

Completed

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics

Rhinitis

Japan
Vanderbilt University

Completed

Is Levocetirizine Less Sedating Than Cetirizine?

Allergic Rhinitis

United States
Sanofi

Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

Rhinitis Perennial

Japan
Sanofi

Completed

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

Cat Induced Allergic Rhinitis
Sanofi

Completed

Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen

Allergic Rhinitis

United States
Organon and Co

Completed

An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)

Urticaria
Organon and Co

Completed

Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

Rhinitis | Urticaria
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Opella Healthcare Group SAS, a Sanofi Company

Completed

A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis (FEXPRESAR)

Seasonal Allergic Rhinitis

Canada
Stanford University

Terminated

Fexofenadine Use in Gastroesophageal Reflux Symptoms

Gastroesophageal Reflux

United States
UCB Pharma

Completed

Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

Allergic Rhinitis
UCB Pharma

Completed

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Rhinitis, Allergic, Seasonal
Damanhour University

Completed

Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers (DPF)

Healthy
UCB Pharma

Completed

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Handok Inc.

Completed

Fexofenadine in Pruritic Skin Disease

Pruritus

Korea, Republic of
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition

Healthy

United States
Wake Forest University Health Sciences

Completed

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Lymphoma | Leukemia

United States
UCB Pharma

Completed

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Rhinitis | Allergic | Seasonal
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Rhinitis | Allergic | Perennial
Sanofi

Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Japan
Xian-Janssen Pharmaceutical Ltd.

Completed

A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers

Healthy
GlaxoSmithKline

Completed

Study Of Perennial Allergic Rhinitis In Pediatrics

Rhinitis, Allergic, Perennial
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions

Healthy

Canada
Organon and Co

Completed

Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)

Asthma | Rhinitis, Allergic, Seasonal
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Fed

United States
AHS Cancer Control Alberta

Not yet recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

Stem Cell Transplant Complications

Canada
Nektar Therapeutics
Eli Lilly and Company

Completed

A Phase I Study of LY3471851 in Healthy Participants

Healthy

United States
Sanofi

Completed

Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants (FEXPOLSAR)

Rhinitis Seasonal

Canada
Organon and Co

Completed

Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)

Rhinitis, Allergic, Seasonal
Tanta University

Completed

Role of Fexofenadine in Diabetic Kidney Disease

Diabetic Kidney Disease

Egypt
University of Michigan

Terminated

Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use

Bone Pain

United States
UCB Pharma

Completed

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Urticaria
Ranbaxy Laboratories Limited
Ohm Laboratories, Inc.

Completed

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Healthy

United States
Organon and Co

Terminated

A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)

Urticaria
Organon and Co

Completed

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Chronic Idiopathic Urticaria | Atopy
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

Fasting

United States
Indiana University

Terminated

The Effect of Cetirizine HCl on Exercise-induced Arterial Hypoxemia in Highly-trained Swimmers

Exercise-induced Arterial Hypoxemia

United States
GlaxoSmithKline

Completed

Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics

Pruritus
Organon and Co

Completed

A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)

Conjunctivitis, Allergic
Charite University, Berlin, Germany
Essex Pharma GmbH

Completed

Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU) (AUD2OCU)

Chronic Urticaria

Germany
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Utrecht Institute for Pharmaceutical Sciences
Royal Netherlands Navy

Completed

Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving

Healthy Volunteers

Netherlands
GlaxoSmithKline

Completed

Study Of Atopic Dermatitis In Pediatrics

Dermatitis, Atopic
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Healthy

Canada
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

Chronic Spontaneous Urticaria

China, France, Spain, Argentina, Germany, Japan, United States, Canada, Hungary, Russian Federation, United Kingdom

3

Subscribe